|
|
||||||||
1 Department of Pediatrics, Stanford University, Stanford, California 94305; and 2 Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio 45267-0575
Deficiency of
phospholamban (PLB) results in enhancement of basal murine cardiac
function and an attenuated response to
-adrenergic stimulation. To
determine whether the absence of PLB also reduces the reserve capacity
of the murine cardiovascular system to respond to stress, we evaluated
the heart rate (HR), blood pressure, and metabolic responses of
PLB-deficient (PLB
/
) mice to graded treadmill exercise
(GTE). PLB
/
mice were hypertensive at rest (125 ± 19 vs. 109 ± 16 mmHg, P < 0.05) but
had normal tachycardic and hypotensive responses to isoproterenol. The
HR response to GTE was normal; however, the hypertension in
PLB
/
mice normalized at peak exercise. Their exercise
capacities, as measured by duration of exercise and peak oxygen
consumption (
O2), were
normal. The oxygen pulse (
O2/HR) curve was also
normal in PLB
/
mice, suggesting an ability to
appropriately increase stroke volume and oxygen extraction during GTE,
despite an inability to increase
-adrenergically stimulated cardiac
contractility. Thus deficiency of PLB, although resulting in diminished
-adrenergic inotropic reserve, does not compromise cardiac
performance during exercise.
treadmill; oxygen pulse; oxygen consumption; contractility; adrenergic
This article has been cited by other articles:
![]() |
D. Bernstein Exercise assessment of transgenic models of human cardiovascular disease Physiol Genomics, May 13, 2003; 13(3): 217 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Kemi, J. P. Loennechen, U. Wisloff, and O. Ellingsen Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy J Appl Physiol, October 1, 2002; 93(4): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain, H. DerSimonian, D. A. Brenner, S. Ngoy, P. Teller, A. S. B. Edge, A. Zawadzka, K. Wetzel, D. B. Sawyer, W. S. Colucci, et al. Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction Circulation, April 10, 2001; 103(14): 1920 - 1927. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |